Author information:
(1)Shanghai Hengrui Pharmaceutical Co., Ltd., 279 Wenjing Road, Shanghai 200245, 
China. Electronic address: lix@shhrp.com.
(2)Jiangsu Hengrui Medicine Co., Ltd., Jiangsu, Lianyungang 222047, China. 
Electronic address: yangcy@shhrp.com.
(3)Shanghai Hengrui Pharmaceutical Co., Ltd., 279 Wenjing Road, Shanghai 200245, 
China. Electronic address: wanh@shhrp.com.
(4)Jiangsu Hengrui Medicine Co., Ltd., Jiangsu, Lianyungang 222047, China. 
Electronic address: zhangge@shhrp.com.
(5)Shanghai Hengrui Pharmaceutical Co., Ltd., 279 Wenjing Road, Shanghai 200245, 
China. Electronic address: fengj@shhrp.com.
(6)Shanghai Hengrui Pharmaceutical Co., Ltd., 279 Wenjing Road, Shanghai 200245, 
China. Electronic address: zhangl@shhrp.com.
(7)State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, 
Chinese Academy of Sciences, Shanghai 201203, China. Electronic address: 
xychen@simm.ac.cn.
(8)State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, 
Chinese Academy of Sciences, Shanghai 201203, China. Electronic address: 
dfzhong@simm.ac.cn.
(9)State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, 
Chinese Academy of Sciences, Shanghai 201203, China. Electronic address: 
lglou@mail.shcnc.ac.cn.
(10)Shanghai Hengrui Pharmaceutical Co., Ltd., 279 Wenjing Road, Shanghai 
200245, China. Electronic address: taowk@shhrp.com.
(11)Jiangsu Hengrui Medicine Co., Ltd., Jiangsu, Lianyungang 222047, China; 
China Pharmaceutical University, Jiangsu Key Laboratory of Drug Design and 
Optimization, Nanjing 210009, China. Electronic address: 
zhanglianshan@hrs.com.cn.